On Dec. 12, 2002, the National Cancer Institute (NCI) announced that a clinical trial had shown that reducing…
On Dec. 5, 2002, the international Mouse Genome Sequencing Consortium announced the publication of a high-quality draft sequence…
On Dec. 3, 2002, Genentech drug Pegasys (peginterferon alfa-2a) was approved by the Food and Drug Administration (FDA)…
On Dec. 1, 202, Sidney Kimmel, founder and chairman of Jones Apparel Group, donated $150 million for cancer…
On Nov. 12, 2002, Cialis, a medication to treat male erectile dysfunction, manufactured by Eli Lilly and Company,…
On Oct. 29, 2002, an international research consortium launched a $100 million public-private effort to create the next…
On Oct. 16, 2002, patterns of proteins found in patients’ blood may help distinguish between prostate cancer and…
On Oct. 10, 2002, the Oregon Opportunity arrived as Oregon Health & Science University (OHSU) broke ground for…
On Sept. 18, 2002, the National Cancer Institute launched the National Lung Screening Trial to compare two ways…
On Sept. 10, 2002, the Public Health Security and Bioterrorism Preparedness and Response Act (P.L. 107-188) was passed…
In Sept. 2002, the Alberta Innovates Centre for Carbohydrate Science (now Alberta Glycomics Centre), began operation with a…
On Aug. 5, 2002, President George W. Bush appointed Richard H. Carmona as U.S. Surgeon General, one of…
On Jul. 22, 2002, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved Aranesp (darbepoetin…
On Jul. 17, 2002, A National Cancer Institute funded trial showed that postmenopausal women who used estrogen replacement…
On Jul. 16, 2002, Amgen completed it’s acquisition of Immunex Corporation for $16 billion in stock and net…
On Jul. 9, 2002, the U.S. Centers for Disease Control and Prevention (CDC) reported newborn HIV infection reductions…
On Jun. 24, 2002, researchers at the University of Minnesota Stem Cell Institute (SCI) announced they had found…
On Jun. 21, 2002, all 53 Member States in the WHO European Region were certified polio free by…
On Jun. 19, 2002, National Cancer Institute (NCI) scientists used microarray technology to determine the patterns of genes…
On Jun. 12, 2002, President George W. Bush signed the Public Health Security and Bioterrorism Preparedness and Response…
On Jun. 8, 2002, the Salt River Pima-Maricopa Indian Community pledged $5 million to the Translational Genomics Research…
In Jun. 2002, the Translational Genomics Research Institute (TGen), a non-profit 501(c)(3) organization focused on developing earlier diagnostics…
On May 19, 2002, researchers from the National Cancer Institute reported that the molecularly targeted drug bevacizumab slowed…
On May 14, 2002, President George W. Bush signed the Hematologic Cancer Research Investment and Education Act of…
On May 14, 2002, the Food and Drug Administration (FDA) approved for use an additional combined diphtheria and…
On May 14, 2002, the International Genomics Consortium (IGC) selected Phoenix for its headquarters. The mission of the…
On May 7, 2002, Quinton Cardiology Systems held its Initial Public Offering raising $28 million. The Bothell, Washington…
In May 2002, Governor Hull signed SB 1270 for $5 million over 10 years for genomic research. Later…
On Apr. 15, 2002, BOTOX(R) cosmetic (onabotulinumtoxinA), manufactured by Allergan, was approved by the Food and Drug Administration…
On Apr. 9, 2002, the American Chemical Society awarded the Priestley Medal to Allen J. Bard ‘for his…